Alliancebernstein L.P. Novartis Ag Transaction History
Alliancebernstein L.P.
- $280 Billion
- Q4 2024
A detailed history of Alliancebernstein L.P. transactions in Novartis Ag stock. As of the latest transaction made, Alliancebernstein L.P. holds 47,158 shares of NVS stock, worth $5.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,158
Previous 34,974
34.84%
Holding current value
$5.24 Million
Previous $4.02 Million
14.07%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding NVS
# of Institutions
1,494Shares Held
130MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.36 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.23 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$910 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$764 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$620 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $239B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...